 |
449 Diseases |  |
58 Trials |
|
58 Trials |  |
3605 News |  |
| «12...13141516171819202122232425» |
- Campath (alemtuzumab) / Sanofi, Leukine (sargramostim) / Partner Therap, Rituxan (rituximab) / Roche
Trial completion date: Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia (clinicaltrials.gov) - Apr 27, 2014
P2, N=33, Active, not recruiting, Sponsor: Mayo Clinic
- | Leukine (sargramostim) / Partner Therap
Trial completion: Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia (clinicaltrials.gov) - Apr 15, 2014
P2, N=0, Completed, Sponsor: Sidney Kimmel Comprehensive Cancer Center
Active, not recruiting --> Completed
- ProstVac (rilimogene galvacirepvec) / Bavarian Nordic
Enrollment change, Metastases: Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer (clinicaltrials.gov) - Apr 15, 2014
P2, N=48, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed N=65 --> 48
- ProstVac (rilimogene galvacirepvec) / Bavarian Nordic
Enrollment closed, Metastases: Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer (clinicaltrials.gov) - Apr 15, 2014
P2, N=48, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
N=65 --> 48 Recruiting --> Active, not recruiting
- SurVaxM (SVN53-67/M57-KLH peptide vaccine) / MimiVax
Enrollment closed: Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma (clinicaltrials.gov) - Apr 7, 2014
P1, N=9, Active, not recruiting, Sponsor: Roswell Park Cancer Institute
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Torisel (temsirolimus) / Pfizer, Unituxin (dinutuximab) / United Therapeutics Corp, Ohara Pharma
Trial suspension: Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma (clinicaltrials.gov) - Mar 31, 2014
P2, N=74, Suspended, Sponsor: National Cancer Institute (NCI)
Recruiting --> Active, not recruiting Recruiting --> Suspended
- Sitoiganap (ERC1671) / Epitopoietic Research Corp
Trial initiation date: ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme (clinicaltrials.gov) - Mar 27, 2014
P2, N=84, Recruiting, Sponsor: Daniela A. Bota
Recruiting --> Suspended Initiation date: Dec 2013 --> Mar 2014
- Sitoiganap (ERC1671) / Epitopoietic Research Corp
Enrollment open: ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme (clinicaltrials.gov) - Mar 27, 2014
P2, N=84, Recruiting, Sponsor: Daniela A. Bota
Initiation date: Dec 2013 --> Mar 2014 Not yet recruiting --> Recruiting
- Intron A (interferon ?-2b) / Merck (MSD), Biogen, Leukine (sargramostim) / Partner Therap
Enrollment change, Combination therapy, Metastases: Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA) (clinicaltrials.gov) - Mar 25, 2014
P1, N=33, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Recruiting N=27 --> 33
- Targretin oral (bexarotene oral) / ReXceptor, Leukine (sargramostim) / Partner Therap
Enrollment change: Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia (clinicaltrials.gov) - Mar 19, 2014
P2, N=26, Active, not recruiting, Sponsor: Sidney Kimmel Comprehensive Cancer Center
N=27 --> 33 N=18 --> 26
- Leukine (sargramostim) / Partner Therap, Rituxan (rituximab) / Roche
Enrollment closed: Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma (clinicaltrials.gov) - Mar 19, 2014
P2, N=44, Active, not recruiting, Sponsor: Sidney Kimmel Comprehensive Cancer Center
N=18 --> 26 Completed --> Active, not recruiting
- | Vacc-4x / Bionor
New P1/2 trial, Epigenetic controller: Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir (clinicaltrials.gov) - Mar 17, 2014
P1/2, N=26, Recruiting, Sponsor: Bionor Immuno AS
- Leukine (sargramostim) / Partner Therap, Yervoy (ipilimumab) / BMS
Enrollment closed, Metastases: GIPI: Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma (clinicaltrials.gov) - Mar 5, 2014
P2, N=43, Active, not recruiting, Sponsor: Lynn E. Spitler, MD
Completed --> Active, not recruiting Recruiting --> Active, not recruiting
- Leukine (sargramostim) / Partner Therap, plerixafor / Generic mfg.
Enrollment closed: Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors (clinicaltrials.gov) - Feb 26, 2014
P2, N=48, Active, not recruiting, Sponsor: Washington University School of Medicine
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Leukine (sargramostim) / Partner Therap
Trial completion, Metastases: Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid Tumors (clinicaltrials.gov) - Feb 22, 2014
P1/2, N=0, Completed, Sponsor: Sirius Medicine
Recruiting --> Active, not recruiting Recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap, NN1213 / Novo Nordisk
Trial completion: Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment (clinicaltrials.gov) - Feb 22, 2014
P2, N=74, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting --> Completed Recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap
Trial completion: LUD2002-004: Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas (clinicaltrials.gov) - Feb 22, 2014
P1, N=0, Completed, Sponsor: Ludwig Institute for Cancer Research
Recruiting --> Completed Active, not recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap
Trial completion: Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor (clinicaltrials.gov) - Feb 22, 2014
P1, N=0, Completed, Sponsor: Dana-Farber Cancer Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap, Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion: Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Roswell Park Cancer Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap
Trial completion, Surgery, Post-surgery: Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | mitoxantrone / Generic mfg., cytarabine / Generic mfg.
Trial completion: Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma (clinicaltrials.gov) - Feb 22, 2014
P2, N=3, Completed, Sponsor: Case Comprehensive Cancer Center
No longer recruiting --> Completed Recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap
Trial completion, Metastases: Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed No longer recruiting --> Completed
- | Trial completion, Metastases: Multiple Therapies in Treating Patients With Advanced Neuroblastoma (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Intron A (interferon ?-2b) / Merck (MSD), Biogen, Leukine (sargramostim) / Partner Therap
Trial completion, Combination therapy, Metastases: Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer (clinicaltrials.gov) - Feb 22, 2014
P1/2, N=60, Completed, Sponsor: St. Luke's Medical Center
Active, not recruiting --> Completed Recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap
Trial completion, Metastases: Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer (clinicaltrials.gov) - Feb 22, 2014
P1, N=48, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed Suspended --> Completed
- | Trial completion: Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Suspended --> Completed Active, not recruiting --> Completed
- | Trial completion, Combination therapy: APC8015 and Bevacizumab in Treating Patients With Prostate Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=25, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Tirazone (tirapazamine) / Teclison, SRI International
Trial completion, Combination therapy: Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma (clinicaltrials.gov) - Feb 22, 2014
P2, N=150, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap
Trial completion, Metastases: Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Trial completion: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=42, Completed, Sponsor: Children's Oncology Group
No longer recruiting --> Completed No longer recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap
Trial completion: Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Barbara Ann Karmanos Cancer Institute
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap, NN1213 / Novo Nordisk
Trial completion: Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Eastern Cooperative Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap
Trial completion: Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=35, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap
Trial completion: Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer (clinicaltrials.gov) - Feb 19, 2014
P3, N=0, Completed, Sponsor: Radiation Therapy Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | thiotepa / Generic mfg.
Trial completion: Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma (clinicaltrials.gov) - Feb 19, 2014
P2, N=40, Completed, Sponsor: Herbert Irving Comprehensive Cancer Center
No longer recruiting --> Completed Recruiting --> Completed
- | Trial completion: Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis (clinicaltrials.gov) - Feb 19, 2014
P2, N=75, Completed, Sponsor: Herbert Irving Comprehensive Cancer Center
Recruiting --> Completed Recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap
Trial completion, Combination therapy, Metastases: Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Eastern Cooperative Oncology Group
Recruiting --> Completed Active, not recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap
Trial completion, Metastases: Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=30, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap, NN1213 / Novo Nordisk, Mylotarg (gemtuzumab ozogamicin) / Pfizer
Trial completion: Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Eastern Cooperative Oncology Group
No longer recruiting --> Completed No longer recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap
Trial completion: Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Fred Hutchinson Cancer Research Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap
Trial completion, Metastases: Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=46, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Trial completion: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer (clinicaltrials.gov) - Feb 19, 2014
P3, N=280, Completed, Sponsor: Fred Hutchinson Cancer Research Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap
Trial completion: Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome (clinicaltrials.gov) - Feb 19, 2014
P1, N=1, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: D9803: Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma (clinicaltrials.gov) - Feb 19, 2014
P3, N=702, Completed, Sponsor: Children's Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap, Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion: Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia (clinicaltrials.gov) - Feb 19, 2014
P2, N=22, Completed, Sponsor: University of Maryland
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Rituxan (rituximab) / Roche
Trial completion: Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=25, Completed, Sponsor: University of Maryland
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors (clinicaltrials.gov) - Feb 19, 2014
P2, N=20, Completed, Sponsor: Scripps Health
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap
Trial completion, Metastases: Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors (clinicaltrials.gov) - Feb 19, 2014
P2, N=24, Completed, Sponsor: Georgetown University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | dactinomycin / Generic mfg., vincristine / Generic mfg.
Trial completion: Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma (clinicaltrials.gov) - Feb 19, 2014
P3, N=483, Completed, Sponsor: Children's Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | cyclophosphamide / Generic mfg.
Trial completion: Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=10, Completed, Sponsor: Temple University
No longer recruiting --> Completed Active, not recruiting --> Completed